Skip To Main Content
Mark Dedden on Muck Rack

Mark Dedden

As seen in: Gut Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Mark Dedden’s profile

Articles by Mark Dedden

Residual homing of α4β7-expressing β1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab

|
By Emily Becker, Mark Dedden, Christine Gall, Maximilian Wiendl
| Gut Journal Verified
Emily Becker1, Mark Dedden1, Christine Gall2, Maximilian Wiendl1, Arif Bülent Ekici3, Anja Schulz-Kuhnt1, Anna Schweda1, Caroline Voskens4,5, Ahmed Hegazy6,7,8, Francesco Vitali1, Raja Atreya1,5, Tanja Martina Müller1,5, Imke Atreya1,5, http://orcid.org/0000-0003-4344-1474Markus F Neurath1,5, http://orcid.org/0000-0003-0888-2784Sebastian Zundler1,5 1 Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nürnberg, Erlangen, Bayern, Germany 2 Institute...
Open in Who Shared Issue with article?

Residual homing of α4β7-expressing β1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab

|
By Emily Becker, Mark Dedden, Christine Gall, Maximilian Wiendl
| Gut Journal Verified
Inflammatory bowel disease Residual homing of α4β7-expressing β1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab Emily Becker1, Mark Dedden1, Christine Gall2, Maximilian Wiendl1, Arif Bülent Ekici3, Anja Schulz-Kuhnt1, Anna Schweda1, Caroline Voskens4,5, Ahmed Hegazy6,7,8, Francesco Vitali1, Raja Atreya1,5, Tanja Martina Müller1,5, Imke Atreya1,5, http://orcid.org/0000-0003-4344-1474Markus F Neurath1,5,...
Open in Who Shared Issue with article?
Show More